At about 6.6% of GDP, Thailand’s healthcare expenditure is relatively high. Accordingly, the market value of pharmaceuticals in Thailand has grown rapidly. The incidence of chronic non-communicable diseases and increase in the elderly population are key factors driving the industry in Thailand. However, the drug industry also faces challenges in the form of more regulatory requirements to obtain marketing authorization licenses for drugs to be imported.

In this webinar, Dr. Atthachai Homhuan, director of regulatory affairs at Tilleke & Gibbins, will provide an overview of Thailand’s pharmaceutical market and explain important aspects of its regulatory framework. Then Ms. Kittiya Nopparatrungroj, a consultant in Tilleke & Gibbins’ regulatory affairs practice group, will walk through the requirements for obtaining a marketing authorization and fulfilling other importation requirements in Thailand. Finally, the speakers will describe the pricing scheme and reimbursement for pharmaceutical products in Thailand.